RELMADA THERAPEUTICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
RELMADA THERAPEUTICS, INC. (RLMD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.51 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 15.59M shares, a 28.47% increase year-over-year.
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 12.13M shares, a 36.97% decline year-over-year.
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 19.25M shares, a 24.06% increase year-over-year.
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 15.52M shares, a 15.46% increase year-over-year.
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 20.90M shares, a 53.17% increase from fiscal 2024.
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 13.65M shares, a 31.07% decline from fiscal 2023.
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 19.80M shares, a 30.68% increase from fiscal 2022.
- RELMADA THERAPEUTICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 15.15M shares, a 11.90% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 15.51M shares 10-Q · filed 2026-08-06 | |||||||
| 2026-03-31 | 15.59M shares 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | 20.90M shares 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | 14.90M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 14.91M shares 10-Q · filed 2026-08-06 | |||||||
| 2025-03-31 | 12.13M shares 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | 13.65M shares 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | 14.72M shares 10-Q · filed 2025-11-13 | |||||||
| 2024-06-30 | 14.87M shares 10-Q · filed 2025-08-07 | |||||||
| 2024-03-31 | 19.25M shares 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | 19.80M shares 10-K · filed 2025-03-27 | |||||||
| 2023-09-30 | 15.48M shares 10-Q · filed 2024-11-07 | |||||||
| 2023-06-30 | 15.51M shares 10-Q · filed 2024-08-07 | |||||||
| 2023-03-31 | 15.52M shares 10-Q · filed 2024-05-08 | |||||||
| 2022-12-31 | 15.15M shares 10-K · filed 2024-03-19 | |||||||
| 2022-09-30 | 15.20M shares 10-Q · filed 2023-11-08 | |||||||
| 2022-06-30 | 13.51M shares 10-Q · filed 2023-08-08 | |||||||
| 2022-03-31 | 13.44M shares 10-Q · filed 2023-05-11 | |||||||
| 2021-12-31 | 13.54M shares 10-K · filed 2023-03-23 | |||||||
| 2021-09-30 | 8.29M shares 10-Q · filed 2022-11-10 | |||||||
| 2021-06-30 | 7.91M shares 10-Q · filed 2022-08-11 | |||||||
| 2021-03-31 | 7.96M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 6.58M shares 10-K · filed 2022-03-25 | |||||||
| 2020-09-30 | 6.78M shares 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | 7.04M shares 10-Q · filed 2021-08-10 | |||||||
| 2020-03-31 | 7.16M shares 10-Q · filed 2021-05-12 | |||||||
| 2019-12-31 | 7.26M shares 10-K · filed 2021-03-24 | 7.26M shares 10-K · filed 2021-03-24 | ||||||
| 2019-09-30 | 6.68M shares 10-Q · filed 2019-11-13 | 6.68M shares 10-Q · filed 2020-11-12 | ||||||
| 2019-06-30 | 5.90M shares 10-Q · filed 2020-08-12 | 5.90M shares 10-K · filed 2021-03-24 | 23.61M shares 10-K · filed 2019-09-24 | |||||
| 2019-03-31 | 5.45M shares 10-Q · filed 2020-05-15 | 21.79M shares 10-Q · filed 2019-05-15 | ||||||
| 2018-12-31 | 5.18M shares 10-KT · filed 2020-03-26 | 20.72M shares 10-Q · filed 2019-02-13 | ||||||
| 2018-09-30 | 3.21M shares 10-Q · filed 2019-11-13 | 12.85M shares 10-Q · filed 2018-11-13 | ||||||
| 2018-06-30 | 3.22M shares 10-KT · filed 2020-03-26 | 12.88M shares 10-K · filed 2018-09-28 | ||||||
| 2018-03-31 | 12.39M shares 10-Q · filed 2018-05-14 | 12.39M shares 10-Q · filed 2019-05-15 | ||||||
| 2017-12-31 | 12.28M shares 10-Q · filed 2019-02-13 | |||||||
| 2017-09-30 | 7.80M shares 10-Q · filed 2018-11-13 | |||||||
| 2017-06-30 | 4.46M shares 10-K · filed 2018-09-28 | 4.49M shares 10-K · filed 2017-09-28 | ||||||
| 2017-03-31 | 4.83M shares 10-Q · filed 2017-05-15 | 4.83M shares 10-Q · filed 2017-05-15 | ||||||
| 2016-12-31 | 4.83M shares 10-Q · filed 2017-02-10 | 4.83M shares 10-Q · filed 2018-02-12 | ||||||
| 2016-09-30 | 4.87M shares 10-Q · filed 2017-11-14 | |||||||
| 2016-06-30 | 4.92M shares 10-K · filed 2017-09-28 | |||||||
| 2016-03-31 | 5.14M shares 10-Q · filed 2016-05-09 | 4.44M shares 10-Q · filed 2016-05-09 | ||||||
| 2015-12-31 | 5.11M shares 10-Q · filed 2016-02-05 | |||||||
| 2015-06-30 | 6.31M shares 10-K · filed 2016-09-09 | |||||||
| 2015-03-31 | 6.41M shares 10-Q · filed 2016-05-09 | 32.03M shares 10-Q · filed 2015-05-15 | 6.41M shares 10-Q · filed 2016-05-09 | 32.03M shares 10-Q · filed 2015-05-15 | ||||
| 2014-12-31 | 6.25M shares 10-Q · filed 2016-02-05 | 31.26M shares 10-Q · filed 2015-02-13 | ||||||
| 2014-09-30 | 9.34M shares 10-Q · filed 2015-11-06 | 46.72M shares 10-Q · filed 2014-11-07 | ||||||
| 2014-06-30 | 9.97M shares 10-K · filed 2015-09-11 | 49.85M shares 10-KT · filed 2014-09-09 | ||||||
| 2014-03-31 | 1.17M shares 10-Q · filed 2015-05-15 | 1.17M shares 10-Q · filed 2015-05-15 | ||||||
| 2013-12-31 | 24.40M shares 10-Q · filed 2015-02-13 | 24.40M shares 10-Q · filed 2015-02-13 | 4.88M shares 10-K · filed 2015-09-11 | 243.96M shares 8-K · filed 2014-05-27 | ||||
| 2013-09-30 | 24.40M shares 10-Q · filed 2014-11-07 | |||||||
| 2012-12-31 | 14.05M shares 10-KT · filed 2014-09-09 | 140.47M shares 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |